Mitchell D. Eggers

Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO.

Aria CV, Inc. develops medical devices. It designed to improve the lives of patients living with the disease of pulmonary hypertension. The company was founded by John Scandurra and Karl Vollmers in 20101 and is headquartered in St. Paul, MN.

Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts.

Amigos de las Américas provides training and leadership programmes. It offers summer and gap programs for young people ages 13-25. The company was founded by Guy Bevil Jr. in 1965 and is headquartered in Houston, TX.

Rad Biomed Accelerator Ltd. (Rad Biomed Accelerator) is a venture capital subsidiary of RAD-Bynet Group founded by Yehuda Zisapel and Nava Zisapel in 1992. The firm is headquartered in Tel Aviv, Israel.

Vascular Graft Solutions Ltd. develops a special device to reduce graft failure rate in order to prevent re-do CABG (Coronaly artery bypass grafting) operation and other secondary interventions in coronary patients. The firm has developed the VEST, a novel Venous External STent for vein grafts. The device is kink-resistant external stent which is deployed over the entire vein graft without interfering with or changing the normal course of the CABG procedure. The company was founded by Eyal Orion in 2009 and is headquartered in Tel Aviv, Israel.

Texas Halo Fund Management LLC (Texas Halo Fund) is a venture capital firm founded in 2010 by Andrew Clark and David Steakley. The firm is Headquartered in Houston, Texas.

FineHeart SA manufactures medical devices for cardiovascular space. It offers wirelessly powered and fully-implantable mechanical circulatory support device. The company was founded by Stéphane Garrigue and Philippe Ritter on January 13, 2010 and is headquartered in Pessac, France.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

AtaCor Medical, Inc. develops cardiac medical devices. The firm offers AtaCor pacing system. The company was founded by Rick Sanghera, Alan Marcovecchio, and Sean McGeehan in 2014 and is headquartered in San Clemente, CA.

The Houston Angel Network functions as an alternative investment manager. The private company is based in Houston, TX.

RapidPulse, Inc. is a medical device company that specializes in developing minimally invasive vascular products for ischemic stroke. The company is based in Miami, FL. The company is focused on advancing the development of the RapidPulse™ cyclic aspiration system, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinout of Syntheon LLC, a medical device incubator dedicated to developing innovative products in the medical device industry. The CEO of the company is Sean McBrayer.

Drusolv Therapeutics, Inc. is an American clinical-stage drug company that is developing a high-dose statin for early intervention in age-related macular degeneration. The CEO of the company is John G. Edwards.

Vectorious Medical Technologies Ltd. develops cardiac monitoring system for patients suffering from congestive heart failure. Its system implements a novel approach to long-term, implant-based hemodynamic monitoring that leverages state-of-the-art technologies in the areas of miniature sensing and wireless communications. The company was founded in November by Oren Goldshtein, Eyal Orion and Ronny Winstein 2011 and is headquartered in Tel Aviv, Israel.